Journal profile · Rheumatology
Turkish Journal of Rheumatology
ISSN 1309-0291 · TURKEY · Quarterly · Founded 2009
Turkish Journal of Rheumatology: impact factor 1.3 (journal website); fully open access; review over 12 weeks (community reports); community-reported acceptance: easy; 59 articles in 2025.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, Turkish Journal of Rheumatology's largest topics are Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Systemic Lupus Erythematosus Research, together about 30.2% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Publishes high-impact scientific papers in rheumatology. International independent peer review standards and open-access model ensure research reaches a wide scientific audience.
From the journal's Aims & Scope
Research area (LetPub): Rheumatology
Editor-in-chief Meltem ALKANPublisher website
Editorial board by country: none in mainland China; most named Türkiye 33, United States 4, India 3, Italy 3, Germany 2 (62 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine14.2%
- Spondyloarthritis Studies and TreatmentsMedicine8.6%
- Systemic Lupus Erythematosus ResearchMedicine7.4%
- Systemic Sclerosis and Related DiseasesMedicine6.7%
- Musculoskeletal pain and rehabilitationMedicine6.7%
- Autoimmune and Inflammatory Disorders ResearchMedicine6%
- Vasculitis and related conditionsMedicine5.7%
- Osteoarthritis Treatment and MechanismsMedicine5.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEScopusPubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.3Publisher website ·
- CiteScore (publisher)
- 2.3Publisher website ·
- h-index
- 31OpenAlex ·
- i10-index
- 234OpenAlex ·
- 2-year mean citedness
- 1.94OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 1,501 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 62 | 62 | 996 |
| 2025 | 59 | 59 | 1,163 |
| 2024 | 78 | 78 | 1,079 |
| 2023 | 78 | 78 | 984 |
| 2022 | 40 | 40 | 848 |
| 2021 | 109 | 109 | 735 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 28 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- imagesImages 250 No abstract 5 No tables total of 3imagesLength not stated
- letter to the editorLetter to the Editor 500 No abstract 5 No tables No mediaLength not stated
- original articleOriginal Article 5000 250 (Structured) 50 6 5 or total of 10 imagesLength not stated
- review articleReview Article 5000 250 100 6 10 or total of 15 imagesLength not stated
Policy excerpts from the journal's websiteLicense & copyright, Self-archiving, Trial registration / reporting guidelines
- License & copyright
Copyright retained by authors; CC BY 4.0 license Model summary
Authors retain the copyright of their published work in Archives of Rheumatology, and scientific articles are licensed under CC BY 4.0.
Source ↗Publisher website ·- Self-archiving
Encourages following SAGER guidelines for sex and gender considerations. Model summary
Archives of Rheumatology encourages authors to follow the ‘Sex and Gender Equity in Research – SAGER – guidelines’ when preparing their manuscripts to promote the inclusion of sex and gender considerations in research.
Source ↗Publisher website ·- Trial registration / reporting guidelines
Clinical trial registration policy adopted from ICMJE; trials must be registered in a WHO ICTRP primary register or ClinicalTrials.gov. Model summary
Archives of Rheumatology adopts the ICMJE's clinical trial registration policy, which requires that clinical trials must be registered in a publicly accessible registry that is a primary register of the WHO International Trials Registry Platform (ICTRP) or in ClinicalTrials.gov.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Country or region
- TURKEY
- Frequency
- Quarterly
- Founded
- 2009
- ISSN
- 1309-0291
- Society / sponsor
- Turkish League Against Rheumatism
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Turkish Journal of Rheumatology
What is the impact factor of Turkish Journal of Rheumatology?
The journal's website gives an impact factor of 1.3; this is the journal's own figure, as LetPub lists none for it; h-index 31.
How long does peer review take at Turkish Journal of Rheumatology?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Turkish Journal of Rheumatology based?
Of the 62 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Türkiye (33), United States (4) and India (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Turkish Journal of Rheumatology?
The journal's website lists SCIE, Scopus and PubMed; that list has not been checked against each database.
Is Turkish Journal of Rheumatology open access, and what is the APC?
Turkish Journal of Rheumatology is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .